Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Anemia 27Neoplasms 9Multiple Myeloma 7Leukemia 7Lymphoma 6Breast Neoplasms 6Neoplasms, Plasma Cell 5Lymphoma, Non-Hodgkin 4Precancerous Conditions 3Lymphoma, Follicular 3Lung Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Waldenstrom Macroglobulinemia 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Prostatic Neoplasms 2Myelodysplastic Syndromes 2Lymphoproliferative Disorders 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Head and Neck Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sezary Syndrome 1

Interventions

Radiotherapy 6Carboplatin 6Paclitaxel 5Cisplatin 5Gefitinib 3Docetaxel 3Gemcitabine 2Etoposide 2pegfilgrastim 1Vinorelbine 1Thalidomide 1Taxes 1Radiation 1Pemetrexed 1Neoadjuvant Therapy 1Mastectomy, Segmental 1Injections 1Glutamic Acid 1Filgrastim 1Erlotinib Hydrochloride 1Epoetin Alfa 1Chemotherapy, Adjuvant 1Bevacizumab 1Anterior Temporal Lobectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Adenocarcinoma, Bronchiolo-Alveolar × Epoetin Alfa × Clear all
NCT00028938 2021-09-09

Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

Wake Forest University Health Sciences

Phase 3 Completed
1 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡